4-[4-氯-5-(2-氯乙基)-6-(3-甲氧基苯基)-嘧啶-2-基]-吗啉 、 间氨基苯磺酰胺 、 4-(3-methoxy-phenyl)-7-(3-aminosulfonylphenyl)-2-morpholin-4-yl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine 以subsequently, further in the same manner as Example 1-A-09, the desired compound was obtained的产率得到3-[4-(3-hydroxy-phenyl)-2-morpholin-4-yl-5,6-dihydro-pyrrolo[2,3-d]pyrimidin-7-yl]-benzenesulfonamide
参考文献:
名称:
PYRIMIDINE DERIVATIVES AS PI3K INHIBITOR AND USE THEREOF
Pyrimidine derivatives as PI3K inhibitor and use thereof
申请人:Chugai Seiyaku Kabushiki Kaisha
公开号:US08022205B2
公开(公告)日:2011-09-20
A drug is provided that is useful as a preventive or therapeutic for cancer as a result of having superior PI3K inhibitory effects as well as superior stability in the body and water-solubility.
A compound, or pharmaceutically acceptable salt thereof, represented by formula (I):
[wherein, X represents a single bond, etc.; Y represents a single bond, etc. (provided that X and Y are not simultaneously single bonds); Z represents a hydrogen atom, etc.; m represents an integer of 1 or 2; and R1 represents a cyclic substituent].